Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Systematic review of body image measures.

Kling J, Kwakkenbos L, Diedrichs PC, Rumsey N, Frisén A, Brandão MP, Silva AG, Dooley B, Rodgers RF, Fitzgerald A.

Body Image. 2019 Sep;30:170-211. doi: 10.1016/j.bodyim.2019.06.006. Epub 2019 Aug 6. Review.

PMID:
31394462
2.

Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mayes MD, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauvé M, Wigley F, Hudson M, Bartlett SJ.

Rheumatology (Oxford). 2019 Jun 5. pii: kez234. doi: 10.1093/rheumatology/kez234. [Epub ahead of print] No abstract available.

PMID:
31168593
3.

Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study.

Becetti K, Kwakkenbos L, Carrier ME, Gordon JK, Nguyen JT, Mancuso CA, Mouthon L, Nguyen C, Rannou F, Welling J, Thombs BD, Spiera RF; SPIN Investigators.

J Rheumatol. 2019 May 1. pii: jrheum.181130. doi: 10.3899/jrheum.181130. [Epub ahead of print]

PMID:
31043542
4.

Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort.

Harel D, Mills SD, Kwakkenbos L, Carrier ME, Nielsen K, Portales A, Bartlett SJ, Malcarne VL, Thombs BD; and the SPIN Investigators.

BMJ Open. 2019 Feb 22;9(2):e024010. doi: 10.1136/bmjopen-2018-024010.

5.

Protocol for the development of a CONSORT extension for RCTs using cohorts and routinely collected health data.

Kwakkenbos L, Juszczak E, Hemkens LG, Sampson M, Fröbert O, Relton C, Gale C, Zwarenstein M, Langan SM, Moher D, Boutron I, Ravaud P, Campbell MK, Mc Cord KA, van Staa TP, Thabane L, Uher R, Verkooijen HM, Benchimol EI, Erlinge D, Sauvé M, Torgerson D, Thombs BD.

Res Integr Peer Rev. 2018 Oct 29;3:9. doi: 10.1186/s41073-018-0053-3. eCollection 2018.

6.

The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study.

Kwakkenbos L, Sanchez TA, Turner KA, Mouthon L, Carrier ME, Hudson M, van den Ende CHM, Schouffoer AA, Welling JJKC, Sauvé M, Thombs BD; the SPIN Investigators.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):88-94. Epub 2018 Sep 29.

7.

Don't forget about the "R" in cmRCT: reply to Groenwold and van Smeden.

Verkooijen HM, Couwenberg A, May A, Thombs B, Kwakkenbos L, Zwarenstein M.

J Clin Epidemiol. 2019 Feb;106:143-144. doi: 10.1016/j.jclinepi.2018.08.012. Epub 2018 Aug 23. No abstract available.

PMID:
30145324
8.

Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data.

Kwakkenbos L, Imran M, McCord KA, Sampson M, Fröbert O, Gale C, Hemkens LG, Langan SM, Moher D, Relton C, Zwarenstein M, Benchimol EI, Boutron I, Campbell MK, Erlinge D, Jawad S, Ravaud P, Rice DB, Sauve M, van Staa TP, Thabane L, Uher R, Verkooijen HM, Juszczak E, Thombs BD.

BMJ Open. 2018 Aug 5;8(8):e025266. doi: 10.1136/bmjopen-2018-025266.

9.

The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.

Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD; SPIN Investigators.

Rheumatology (Oxford). 2018 Sep 1;57(9):1623-1631. doi: 10.1093/rheumatology/key139.

PMID:
29868924
10.

Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale.

Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B.

Psychooncology. 2018 Nov;27(11):2609-2615. doi: 10.1002/pon.4782. Epub 2018 Jun 14.

PMID:
29843189
11.

Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.

Merz EL, Kwakkenbos L, Carrier ME, Gholizadeh S, Mills SD, Fox RS, Jewett LR, Williamson H, Harcourt D, Assassi S, Furst DE, Gottesman K, Mayes MD, Moss TP, Thombs BD, Malcarne VL; SPIN Investigators.

BMJ Open. 2018 Mar 6;8(3):e018641. doi: 10.1136/bmjopen-2017-018641. Erratum in: BMJ Open. 2018 May 5;8(5):.

12.

Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Fox RS, Kwakkenbos L, Carrier ME, Mills SD, Gholizadeh S, Jewett LR, Roesch SC, Merz EL, Assassi S, Furst DE, Gottesman K, Mayes MD, Thombs BD, Malcarne VL; SPIN Investigators.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1646-1652. doi: 10.1002/acr.23532.

PMID:
29409146
13.

Structural validation of the Self-Compassion Scale with a German general population sample.

Coroiu A, Kwakkenbos L, Moran C, Thombs B, Albani C, Bourkas S, Zenger M, Brahler E, Körner A.

PLoS One. 2018 Feb 6;13(2):e0190771. doi: 10.1371/journal.pone.0190771. eCollection 2018.

14.

Validation of the Social Appearance Anxiety Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Mills SD, Kwakkenbos L, Carrier ME, Gholizadeh S, Fox RS, Jewett LR, Gottesman K, Roesch SC, Thombs BD, Malcarne VL; Scleroderma Patient-centered Intervention Network Investigators.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1557-1562. doi: 10.1002/acr.23514.

PMID:
29342510
15.

Addressing overestimation of the prevalence of depression based on self-report screening questionnaires.

Thombs BD, Kwakkenbos L, Levis AW, Benedetti A.

CMAJ. 2018 Jan 15;190(2):E44-E49. doi: 10.1503/cmaj.170691. No abstract available.

16.

Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey.

Gumuchian ST, Delisle VC, Kwakkenbos L, Pépin M, Carrier ME, Malcarne VL, Peláez S, El-Baalbaki G, Thombs BD; Scleroderma Support Group Project Advisory Team.

Disabil Rehabil. 2019 Apr;41(8):974-982. doi: 10.1080/09638288.2017.1416497. Epub 2017 Dec 19.

PMID:
29254393
17.

Understanding coping strategies among people living with scleroderma: a focus group study.

Gumuchian ST, Peláez S, Delisle VC, Carrier ME, Jewett LR, El-Baalbaki G, Fortune C, Hudson M, Körner A, Kwakkenbos L, Bartlett SJ, Thombs BD.

Disabil Rehabil. 2018 Dec;40(25):3012-3021. doi: 10.1080/09638288.2017.1365954. Epub 2017 Aug 17.

PMID:
28817964
18.

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.

Coebergh van den Braak RRJ, van Rijssen LB, van Kleef JJ, Vink GR, Berbee M, van Berge Henegouwen MI, Bloemendal HJ, Bruno MJ, Burgmans MC, Busch ORC, Coene PPLO, Coupé VMH, Dekker JWT, van Eijck CHJ, Elferink MAG, Erdkamp FLG, van Grevenstein WMU, de Groot JWB, van Grieken NCT, de Hingh IHJT, Hulshof MCCM, Ijzermans JNM, Kwakkenbos L, Lemmens VEPP, Los M, Meijer GA, Molenaar IQ, Nieuwenhuijzen GAP, de Noo ME, van de Poll-Franse LV, Punt CJA, Rietbroek RC, Roeloffzen WWH, Rozema T, Ruurda JP, van Sandick JW, Schiphorst AHW, Schipper H, Siersema PD, Slingerland M, Sommeijer DW, Spaander MCW, Sprangers MAG, Stockmann HBAC, Strijker M, van Tienhoven G, Timmermans LM, Tjin-A-Ton MLR, van der Velden AMT, Verhaar MJ, Verkooijen HM, Vles WJ, de Vos-Geelen JMPGM, Wilmink JW, Zimmerman DDE, van Oijen MGH, Koopman M, Besselink MGH, van Laarhoven HWM; Dutch Pancreatic Cancer Group, Dutch Upper GI Cancer Group and PLCRC working group.

Acta Oncol. 2018 Feb;57(2):195-202. doi: 10.1080/0284186X.2017.1346381. Epub 2017 Jul 19.

PMID:
28723307
19.

Assessment of English-French differential item functioning of the Satisfaction with Appearance Scale (SWAP) in systemic sclerosis.

Jewett LR, Kwakkenbos L, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group.

Body Image. 2017 Sep;22:97-102. doi: 10.1016/j.bodyim.2017.06.005. Epub 2017 Jul 13.

PMID:
28711486
20.

Exercise habits and factors associated with exercise in systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.

Azar M, Rice DB, Kwakkenbos L, Carrier ME, Shrier I, Bartlett SJ, Hudson M, Mouthon L, Poiraudeau S, van den Ende CHM, Johnson SR, Rodriguez Reyna TS, Schouffoer AA, Welling J, Thombs BD; SPIN investigators.

Disabil Rehabil. 2018 Aug;40(17):1997-2003. doi: 10.1080/09638288.2017.1323023. Epub 2017 May 8.

PMID:
28478701
21.

Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mayes MD, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauvé M, Wigley F, Hudson M, Bartlett SJ; SPIN Investigators.

Rheumatology (Oxford). 2017 Aug 1;56(8):1302-1311. doi: 10.1093/rheumatology/kex055.

22.

Three-year trajectories of disability and fatigue in systemic sclerosis: a cohort study.

Willems LM, Kwakkenbos L, Vonk MC, van den Hoogen FHJ, Vliet Vlieland TPM, van den Ende CHM.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):48-55. Epub 2017 Mar 8.

PMID:
28281452
23.

Reasons for Not Participating in Scleroderma Patient Support Groups: A Cross-Sectional Study.

Gumuchian ST, Delisle VC, Peláez S, Malcarne VL, El-Baalbaki G, Kwakkenbos L, Jewett LR, Carrier ME, Pépin M, Thombs BD; the Scleroderma Support Group Project Advisory Team.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):275-283. doi: 10.1002/acr.23220. Epub 2018 Jan 11.

24.

Validation of the Body Concealment Scale for Scleroderma (BCSS): Replication in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort.

Jewett LR, Kwakkenbos L, Carrier ME, Malcarne VL, Harcourt D, Rumsey N, Mayes MD, Assassi S, Körner A, Fox RS, Gholizadeh S, Mills SD, Fortune C, Thombs BD; SPIN Investigators, Baron M, Bartlett SJ, Furst D, Gottesman K, van den Hoogen F, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauve M, Wigley F, Boutron I, Costa Maia A, El-Baalbaki G, Ells C, van den Ende C, Fligelstone K, Fortune C, Frech T, Godard D, Harel D, Hudson M, Impens A, Jang Y, Johnson SR, Kennedy AT, Khanna D, Larche M, Leite C, Marra C, Nielsen K, Poole JL, Pope J, Rodriguez Reyna TS, Schouffoer AA, Steele RJ, Suarez-Almazor ME, Welling J, Wong-Rieger D, Albert A, Arsenault G, Bissonnette L, Boire G, Bruns A, Carreira P, Chung L, Dagenais P, Denton C, Domsic R, Dunne JV, Fortin P, Gill A, Gordon J, Gyger G, Herrick AL, Hinchcliff M, Ikic A, Jones N, de B Fernandes AJ, Kafaja S, Khalidi N, Korman B, Liang P, Manning J, Masetto A, Portales A, Robinson D, Roux S, Schiopu E, Smith D, Spiera R, Steen V, Sutton E, Thorne C, Varga J, Wilcox P, Delisle VC, Fedoruk C, Levis B, Pepin MR, Persmann J.

Body Image. 2017 Mar;20:99-106. doi: 10.1016/j.bodyim.2016.11.007. Epub 2017 Jan 6.

PMID:
28068643
25.

The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Levis B, Kwakkenbos L, Hudson M, Baron M, Thombs BD; and the Canadian Scleroderma Research Group.

Clin Rheumatol. 2017 Feb;36(2):373-379. doi: 10.1007/s10067-016-3501-9. Epub 2016 Dec 10.

PMID:
27943045
26.

Comparison of Self-Efficacy for Managing Chronic Disease between patients with systemic sclerosis and other chronic conditions: a systematic review.

Thombs BD, Kwakkenbos L, Riehm KE, Saadat N, Fedoruk C.

Rheumatol Int. 2017 Feb;37(2):281-292. doi: 10.1007/s00296-016-3602-4. Epub 2016 Nov 19. Review.

PMID:
27866246
27.

Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Levis AW, Harel D, Kwakkenbos L, Carrier ME, Mouthon L, Poiraudeau S, Bartlett SJ, Khanna D, Malcarne VL, Sauve M, van den Ende CH, Poole JL, Schouffoer AA, Welling J, Thombs BD; the Scleroderma Patient-Centered Intervention Network Investigators.

Arthritis Care Res (Hoboken). 2016 Nov;68(11):1704-1713. doi: 10.1002/acr.22893. Epub 2016 Oct 9.

28.

Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

Jewett LR, Kwakkenbos L, Carrier ME, Malcarne VL, Bartlett SJ, Furst DE, Gottesman K, Mayes MD, Assassi S, Harcourt D, Williamson H, Johnson SR, Körner A, Steen V, Fox RS, Gholizadeh S, Mills SD, Molnar JC, Rice DB, Thombs BD; and the SPIN Investigators.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):92-99. Epub 2016 Aug 1.

PMID:
27494308
29.

Reporting of Positive Results in Randomized Controlled Trials of Mindfulness-Based Mental Health Interventions.

Coronado-Montoya S, Levis AW, Kwakkenbos L, Steele RJ, Turner EH, Thombs BD.

PLoS One. 2016 Apr 8;11(4):e0153220. doi: 10.1371/journal.pone.0153220. eCollection 2016.

30.

Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study.

Gumuchian ST, Peláez S, Delisle VC, Carrier ME, Jewett LR, El-Baalbaki G, Fortune C, Hudson M, Impens A, Körner A, Persmann J, Kwakkenbos L, Bartlett SJ, Thombs BD.

PLoS One. 2016 Mar 23;11(3):e0152419. doi: 10.1371/journal.pone.0152419. eCollection 2016.

31.

Development and Validation of the Body Concealment Scale for Scleroderma.

Jewett LR, Malcarne VL, Kwakkenbos L, Harcourt D, Rumsey N, Körner A, Steele RJ, Hudson M, Baron M, Haythornthwaite JA, Heinberg L, Wigley FM, Thombs BD; Canadian Scleroderma Research Group.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1158-65. doi: 10.1002/acr.22819.

32.

Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study.

Riehm KE, Kwakkenbos L, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Nielsen K, Baron M, Frech T, Hudson M, Pope J, Sauve M, Suarez-Almazor ME, Wigley FM, Thombs BD; Scleroderma Patient-Centered Intervention Network Investigators.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1195-200. doi: 10.1002/acr.22807.

33.

Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study.

Levis B, Rice DB, Kwakkenbos L, Steele RJ, Hagedoorn M, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1143-9. doi: 10.1002/acr.22802.

34.

Psychosocial Aspects of Scleroderma.

Kwakkenbos L, Delisle VC, Fox RS, Gholizadeh S, Jewett LR, Levis B, Milette K, Mills SD, Malcarne VL, Thombs BD.

Rheum Dis Clin North Am. 2015 Aug;41(3):519-28. doi: 10.1016/j.rdc.2015.04.010. Epub 2015 May 27. Review.

PMID:
26210133
35.

Can the Cancer-related Fatigue Case-definition Criteria Be Applied to Chronic Medical Illness? A Comparison between Breast Cancer and Systemic Sclerosis.

Kwakkenbos L, Minton O, Stone PC, Alexander S, Baron M, Hudson M, Thombs BD; Canadian Scleroderma Research Group.

J Rheumatol. 2015 Jul;42(7):1156-62. doi: 10.3899/jrheum.141421. Epub 2015 Jun 1.

PMID:
26034154
36.

Effectiveness of Nonpharmacologic Interventions in Systemic Sclerosis: A Systematic Review.

Willems LM, Vriezekolk JE, Schouffoer AA, Poole JL, Stamm TA, Boström C, Kwakkenbos L, Vliet Vlieland TP, van den Ende CH.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1426-39. doi: 10.1002/acr.22595. Review.

37.

Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries.

Willems LM, Kwakkenbos L, Leite CC, Thombs BD, van den Hoogen FH, Maia AC, Vliet Vlieland TP, van den Ende CH.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-88-93. Epub 2014 Nov 3.

PMID:
25372793
38.

Cognitive-behavioural therapy targeting fear of progression in an interdisciplinary care program: a case study in systemic sclerosis.

Kwakkenbos L, Willems LM, van den Hoogen FH, van Lankveld WG, Beenackers H, van Helmond TF, Becker ES, van den Ende CH.

J Clin Psychol Med Settings. 2014 Dec;21(4):297-312. doi: 10.1007/s10880-014-9414-3.

PMID:
25358547
39.

Spirituality and Negative Emotions in Individuals With Coronary Heart Disease.

Ginting H, Näring G, Kwakkenbos L, Becker ES.

J Cardiovasc Nurs. 2015 Nov-Dec;30(6):537-45. doi: 10.1097/JCN.0000000000000201.

PMID:
25350528
40.

Major depression diagnoses among patients with systemic sclerosis: baseline and one-month followup.

Thombs BD, Jewett LR, Kwakkenbos L, Hudson M, Baron M; Canadian Scleroderma Research Group.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):411-6. doi: 10.1002/acr.22447.

41.

An assessment of the measurement equivalence of English and French versions of the Center for Epidemiologic Studies Depression (CES-D) Scale in systemic sclerosis.

Delisle VC, Kwakkenbos L, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group.

PLoS One. 2014 Jul 18;9(7):e102897. doi: 10.1371/journal.pone.0102897. eCollection 2014.

42.

Prevalence of posttraumatic stress disorder (PTSD) in women with breast cancer.

Kwakkenbos L, Coyne JC, Thombs BD.

J Psychosom Res. 2014 Jun;76(6):485-6. doi: 10.1016/j.jpsychores.2014.03.103. Epub 2014 Apr 6. No abstract available.

PMID:
24840144
43.

Trial registration in rheumatology: the next step.

Thombs BD, Kwakkenbos L, Coronado-Montoya S.

Arthritis Care Res (Hoboken). 2014 Oct;66(10):1435-7. doi: 10.1002/acr.22335. No abstract available.

44.

The comparability of English, French and Dutch scores on the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F): an assessment of differential item functioning in patients with systemic sclerosis.

Kwakkenbos L, Willems LM, Baron M, Hudson M, Cella D, van den Ende CH, Thombs BD; Canadian Scleroderma Research Group.

PLoS One. 2014 Mar 17;9(3):e91979. doi: 10.1371/journal.pone.0091979. eCollection 2014.

45.

Health care use and patients' perceptions on quality of care in systemic sclerosis.

Willems LM, Kwakkenbos L, Bode C, van den Hoogen FH, van den Ende CH.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):64-70. Epub 2013 Jul 22.

PMID:
23910612
46.

A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.

Kwakkenbos L, Fransen J, Vonk MC, Becker ES, Jeurissen M, van den Hoogen FH, van den Ende CH.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):50-6. Epub 2013 Jul 22.

PMID:
23910610
47.

The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.

Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K, Khanna D, Malcarne VL, Mayes MD, Mouthon L, Poiraudeau S, Sauve M, Nielson WR, Poole JL, Assassi S, Boutron I, Ells C, van den Ende CH, Hudson M, Impens A, Körner A, Leite C, Costa Maia A, Mendelson C, Pope J, Steele RJ, Suarez-Almazor ME, Ahmed S, Coronado-Montoya S, Delisle VC, Gholizadeh S, Jang Y, Levis B, Milette K, Mills SD, Razykov I, Fox RS, Thombs BD.

BMJ Open. 2013 Aug 7;3(8). pii: e003563. doi: 10.1136/bmjopen-2013-003563.

48.

Reassessing the clinical utility of the Patient Health Questionnaire (PHQ)-9 for depression screening in prenatal women: a commentary on Sidebottom et al.

Coronado-Montoya S, Kwakkenbos L, Levis B, Thombs BD.

Arch Womens Ment Health. 2013 Jun;16(3):253-4. doi: 10.1007/s00737-013-0340-4. Epub 2013 Apr 5. No abstract available.

PMID:
23558946
49.

Cross-language measurement equivalence of the Center for Epidemiologic Studies Depression (CES-D) scale in systemic sclerosis: a comparison of Canadian and Dutch patients.

Kwakkenbos L, Arthurs E, van den Hoogen FH, Hudson M, van Lankveld WG, Baron M, van den Ende CH, Thombs BD; Canadian Scleroderma Research Group.

PLoS One. 2013;8(1):e53923. doi: 10.1371/journal.pone.0053923. Epub 2013 Jan 11.

50.

Triple P-Positive Parenting programs: the folly of basing social policy on underpowered flawed studies.

Coyne JC, Kwakkenbos L.

BMC Med. 2013 Jan 16;11:11. doi: 10.1186/1741-7015-11-11.

Supplemental Content

Loading ...
Support Center